Analytical Data
-
基因名
vpl1
- Application
-
别名
vpl1；Versatile peroxidase VPL1
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q9UR19
-
表达区间
31-361aa
-
氨基酸序列
ATCADGRTTANAACCVLFPILDDIQENLFDGAQCGEEVHESLRLTFHDAIGFSPTLGGGGADGSIIAFDTIETNFPANAGIDEIVSAQKPFVAKHNISAGDFIQFAGAVGVSNCPGGVRIPFFLGRPDAVAASPDHLVPEPFDSVDSILARMSDAGFSPVEVVWLLASHSIAAADKVDPSIPGTPFDSTPGVFDSQFFIETQLKGRLFPGTADNKGEAQSPLQGEIRLQSDHLLARDPQTACEWQSMVNNQPKIQNRFAATMSKMALLGQDKTKLIDCSDVIPTPPALVGAAHLPAGFSLSDVEQACAATPFPALTADPGPVTSVPPVPGS
-
分子量
42.0 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
VPL1, or Virus Protein L1, is a recombinant protein derived from certain viral structures, primarily studied for its potential applications in vaccine development and therapeutic interventions. Its significance stems from its role in the viral life cycle, particularly in the assembly and release of viral particles. Research into VPL1 has gained momentum due to the increasing need for effective vaccines against various viral infections, including those responsible for significant public health challenges. By characterizing the structure and function of VPL1, scientists aim to understand how it interacts with host immune systems, which can inform the design of recombinant vaccines that elicit robust immune responses. Additionally, the recombinant production of VPL1 in various expression systems, such as yeast, bacteria, or mammalian cells, allows for the mass production of this protein, which can be utilized in immunological studies and as a potential target for antiviral drug development. The ongoing research on VPL1 not only contributes to the foundational knowledge of viral pathogenesis but also holds promise for innovative strategies in disease prevention and treatment, thereby addressing global health needs.
